These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17692005)

  • 1. Molecular regulation and pharmacology of pacemaker channels.
    Bois P; Guinamard R; Chemaly AE; Faivre JF; Bescond J
    Curr Pharm Des; 2007; 13(23):2338-49. PubMed ID: 17692005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D
    Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology and pharmacology of the cardiac pacemaker ("funny") current.
    Baruscotti M; Bucchi A; Difrancesco D
    Pharmacol Ther; 2005 Jul; 107(1):59-79. PubMed ID: 15963351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide.
    Chen S; Wang J; Siegelbaum SA
    J Gen Physiol; 2001 May; 117(5):491-504. PubMed ID: 11331358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of heart rate by cAMP sensitivity of HCN channels.
    Alig J; Marger L; Mesirca P; Ehmke H; Mangoni ME; Isbrandt D
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12189-94. PubMed ID: 19570998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the funny current in pacemaker activity.
    DiFrancesco D
    Circ Res; 2010 Feb; 106(3):434-46. PubMed ID: 20167941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D; Borer JS
    Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I; Szél T; Jaeger K; Baczkó I; Cerbai E; Romanelli MN; Gy Papp J; Varró A
    Curr Med Chem; 2011; 18(24):3662-74. PubMed ID: 21774761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
    J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine.
    Van Bogaert PP; Pittoors F
    Eur J Pharmacol; 2003 Oct; 478(2-3):161-71. PubMed ID: 14575801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current I(f).
    Moroni A; Gorza L; Beltrame M; Gravante B; Vaccari T; Bianchi ME; Altomare C; Longhi R; Heurteaux C; Vitadello M; Malgaroli A; DiFrancesco D
    J Biol Chem; 2001 Aug; 276(31):29233-41. PubMed ID: 11328811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An arginine residue in the pore region is a key determinant of chloride dependence in cardiac pacemaker channels.
    Wahl-Schott C; Baumann L; Zong X; Biel M
    J Biol Chem; 2005 Apr; 280(14):13694-700. PubMed ID: 15644313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node.
    Altomare C; Terragni B; Brioschi C; Milanesi R; Pagliuca C; Viscomi C; Moroni A; Baruscotti M; DiFrancesco D
    J Physiol; 2003 Jun; 549(Pt 2):347-59. PubMed ID: 12702747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.
    DiFrancesco D
    Pharmacol Res; 2006 May; 53(5):399-406. PubMed ID: 16638640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.
    Liao Z; Lockhead D; Larson ED; Proenza C
    J Gen Physiol; 2010 Sep; 136(3):247-58. PubMed ID: 20713547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of hyperpolarization-activated, cyclic nucleotide-gated channel function by the intravenous general anesthetic propofol.
    Cacheaux LP; Topf N; Tibbs GR; Schaefer UR; Levi R; Harrison NL; Abbott GW; Goldstein PA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):517-25. PubMed ID: 16033909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain.
    Monteggia LM; Eisch AJ; Tang MD; Kaczmarek LK; Nestler EJ
    Brain Res Mol Brain Res; 2000 Sep; 81(1-2):129-39. PubMed ID: 11000485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious workings of the funny current.
    DiFrancesco D
    Prog Biophys Mol Biol; 2006; 90(1-3):13-25. PubMed ID: 15975637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCN-related channelopathies.
    Baruscotti M; Bottelli G; Milanesi R; DiFrancesco JC; DiFrancesco D
    Pflugers Arch; 2010 Jul; 460(2):405-15. PubMed ID: 20213494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.